Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Current Leases (2022 - 2025)

Historic Current Leases for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to $9481.8.

  • Addex Therapeutics' Current Leases rose 1386.0% to $9481.8 in Q3 2025 from the same period last year, while for Sep 2025 it was $9481.8, marking a year-over-year increase of 1386.0%. This contributed to the annual value of $8304.7 for FY2024, which is 9727.74% down from last year.
  • Addex Therapeutics' Current Leases amounted to $9481.8 in Q3 2025, which was up 1386.0% from $9048.3 recorded in Q2 2025.
  • Over the past 5 years, Addex Therapeutics' Current Leases peaked at $316291.6 during Q1 2022, and registered a low of $8228.4 during Q1 2025.
  • Its 4-year average for Current Leases is $149218.6, with a median of $222306.1 in 2023.
  • In the last 5 years, Addex Therapeutics' Current Leases tumbled by 9729.96% in 2024 and then surged by 1386.0% in 2025.
  • Quarter analysis of 4 years shows Addex Therapeutics' Current Leases stood at $296985.3 in 2022, then increased by 3.99% to $308845.5 in 2023, then plummeted by 97.3% to $8340.0 in 2024, then increased by 13.69% to $9481.8 in 2025.
  • Its last three reported values are $9481.8 in Q3 2025, $9048.3 for Q2 2025, and $8228.4 during Q1 2025.